IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Thursday, July 25, 2013 to discuss 2nd quarter 2013 results. The Company invites you to listen to the call by dialing 1-866-515-2909. International participants should call 1-617-399-5123. The passcode for the conference call is 19569314. This call is being webcast by Thomson and can be accessed at IGI's website at www.igilabs.com. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents ( www.streetevents.com), a password-protected event management site. About IGI Laboratories, Inc. IGI Laboratories is a developer and manufacturer of topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.